Article Sidebar
Views PDF: 71
INITIAL EXPERIENCES AND SHORTTERM RESULTS OF TRANSCATHETER AORTIC VALVE IMPLANTATION AT 108 CENTRAL MILITARY HOSPITAL
Main Article Content
Abstract
Transcatheter aortic valve implantation (TAVI) for patients with aortic valve stenosis who cannot undergo surgery or do not want surgery is a safe, effective and increasingly popular method. The goal of this study is to describe the first cases of TAVI at 108 Central Military Hospital. In the period of 5 years (2019-2024), we performed 5 TAVI cases. The results: 3 of 5 patients were women, the oldest patient was 90 and the youngest was 69 years old, heart failure symptoms were at different levels with NYHA class ranging from II to IV, the technical and clinical success rate was 100%. There was 1 case of vascular complications causing blood loss and 1 case of increased kidney failure. After TAVI, the patients' symptoms and pressure gradient across the aortic valve improved. Conclusions: TAVI is a safe and effective technique and should be widely deployed at major cardiovascular centers.
Article Details
References
2. Cribier A (2022) Invention and uptake of TAVI over the first 20 years. Nature Reviews Cardiology 19: 427-428.
3. Nhan VT, Khoa NQ, Thuy LT, Van Duong N, Van Tan N, et al. (2024) Early safety and mid-term clinical outcomes of technology transfer of transcatheter aortic valve implantation in patients with severe aortic valve stenosis in Vietnam: a single-center experience of 90 patients. The Lancet Regional Health - Western Pacific 42: 100956.
4. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, et al. (2011) Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. New England Journal of Medicine 364: 2187-2198.
5. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, et al. (2016) Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. New England Journal of Medicine 374: 1609-1620.
6. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, et al. (2019) Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. New England Journal of Medicine 380: 1695-1705.
7. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, et al. (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106: 3006-3008.
8. van Ginkel DJ, Brouwer J, van Hemert ND, Kraaijeveld AO, Rensing B, et al. (2021) Major threats to early safety after transcatheter aortic valve implantation in a contemporary cohort of real-world patients. Neth Heart J 29: 632-642.